What do patients with rheumatoid arthritis know about their own biomedical data related to cardiovascular disease risks?

Código QR

What do patients with rheumatoid arthritis know about their own biomedical data related to cardiovascular disease risks?

Guardado en:

Detalles Bibliográficos
Autores principales:	Tanaka Ngcozana, Kevin Corbett, Ajay Bhatia
Formato:	article
Lenguaje:	EN
Publicado:	AVES Yayincilik 2021
Materias:	Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/d4a04161b8a142b384805c50c9bdd249
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

What cardiologists need to know about cardiovascular magnetic resonance (CMR)
por: J. Cameron Bridgman, et al.
Publicado: (2017)

What we know about ocular manifestations of Ebola
por: Moshirfar M, et al.
Publicado: (2014)

PSYCHOPHYSIOLOGICAL AND IMMUNE STATUS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: T. Y. Abramova, et al.
Publicado: (2014)

RHEUMATOID ARTHRITIS: LABORATORY MODELS OF THE DISEASE
por: I. A. Orlovskaya, et al.
Publicado: (2015)

TELOMERE SHORTENING IN MONOCYTES OF THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: V. I. Borisov, et al.
Publicado: (2014)

Beyond Rheumatoid Arthritis Evaluation: What are We Missing?
por: Espinoza G, et al.
Publicado: (2021)

CLINICAL AND IMMUNOLOGICAL PARAMETERS IN EARLY RHEUMATOID ARTHRITIS
por: V. V. Sokolova, et al.
Publicado: (2014)

Faculty perceptions and knowledge of career development of trainees in biomedical science: What do we (think we) know?
por: Stephanie W Watts, et al.
Publicado: (2019)

What an Interventionalist Needs to Know About MI with Non-obstructive Coronary Arteries
por: Robert Sykes, et al.
Publicado: (2021)

What do medical students actually need to know about artificial intelligence?
por: Liam G. McCoy, et al.
Publicado: (2020)

The culture of impunity: What journalists need to know about international humanitarian law
por: Roderic Alley
Publicado: (2010)

TELOMERIC PROFILE IN B LYMPHOCYTES FROM THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: E. V. Zinnatova, et al.
Publicado: (2014)

Risk of cervical myelopathy in rheumatoid arthritis patients with neck pain
por: Marina W. Gerges, et al.
Publicado: (2022)

Five things to know about genetically modified (GM) insects for vector control.
por: Luke Alphey, et al.
Publicado: (2014)

Heart Rate Variability and Cardiovascular Fitness: What We Know so Far
por: Souza HCD, et al.
Publicado: (2021)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Michael T. Osterholm, et al.
Publicado: (2015)

Public spending and the poor: what we know, what we need to know
por: Van de Walle, Dominique
Publicado: (2014)

The importance of homocysteine in the development of cardiovascular complications in patients with rheumatoid arthritis
por: Jerzy Głuszek, et al.
Publicado: (2020)

Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis.
por: Samuel A Curran, et al.
Publicado: (2014)

PREDICTION OF CLINICAL EFFICIENCY OF SIMVASTATIN TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2014)

Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
por: Jianan Zhao, et al.
Publicado: (2021)

СLINICAL EFFICIENCY OF STATINS IN RHEUMATOID ARTHRITIS: A PILOT STUDY
por: I. V. Shirinsky, et al.
Publicado: (2014)

Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis
por: Liam J. O’Neil, et al.
Publicado: (2021)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Mahendra Rai, et al.
Publicado: (2021)

HETEROGENEITY OF POLYCLONAL IMMUNOGLOBULINS NUCLEASE ACTIVITY IN RHEUMATOID AND REACTIVE ARTHRITIS
por: M. V. Volkova, et al.
Publicado: (2017)

What a patient needs to know about the virus human papillomas and cervical cancer?
por: Sergei P. Sinchikhin, et al.
Publicado: (2021)

What do young Australian adults know about modifiable risk factors for dementia?
por: Hannah A. D. Keage, et al.
Publicado: (2021)

PROBLEM LEARNERS OR STUDENTS WITH LEARNING DISABILITIES? WHAT DO TEACHERS KNOW ABOUT LD?
por: Feyza DOYRAN, et al.
Publicado: (2019)

EFFICACY AND SAFETY OF SIMVASTATIN IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL, CONTROLLED STUDY
por: I. V. Shirinsky, et al.
Publicado: (2014)

Correction to: Factors associated with anxiety and depression in rheumatoid arthritis patients: a cross-sectional study
por: Miyabi Uda, et al.
Publicado: (2021)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
por: Anne Mirjam Kerola, et al.
Publicado: (2021)

A Decade of Mighty Lipophagy: What We Know and What Facts We Need to Know?
por: Muhammad Babar Khawar, et al.
Publicado: (2021)

Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis
por: Karina Rossi Bonfiglioli, et al.
Publicado: (2021)

What Do We Know about Inequalities in NAFLD Distribution and Outcomes? A Scoping Review
por: Mar Talens, et al.
Publicado: (2021)

What you need to know about developing your test-taking skills, writing assessment /
por: Boone, Robert S.
Publicado: (1996)

What do we really know about micronutrient supplementation and risk for upper respiratory infection?
por: Sydne Newberry
Publicado: (2021)

SUBTYPE CHARACTERICS OF DENDRITIC CELLS FROM PERIPHERAL BLOOD OF PATIENTS WITH RHEUMATOID ARTHRITIS
por: S. A. Falaleeva, et al.
Publicado: (2014)

EFFECT OF SIMVASTATIN THERAPY UPON IMMUNOLOGICAL MARKERS OF ATHEROSCLEROSIS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2014)

Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?
por: Giandomenico Bisaccia, et al.
Publicado: (2021)

PLEIOTROPIC EFFECTS OF SIMVASTATIN AND FENOFIBRATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A COMPARATIVE STUDY
por: I. V. Shirinsky, et al.
Publicado: (2019)